Press Contact Global sites About Us Corporate Profile Our Company Vision Values History Diversity & Inclusion Transparency Sustainability Corporate Citizenship Press News Press Releases Image Mediapool Events & Initiatives Media Contacts Annual Press Conference Global Activities Europe North America South America Asia Africa Australasia Products Innovation Research & Development Research Approach Therapeutic Areas Research Beyond Borders Drug Discovery Boehringer Ingelheim Venture Fund Partnering Our Approach Overview What We Offer Partnering Interests Overview How We Engage Overview News & Communications Press Releases Events Partnering Newsletter Contact Us Prescription Medicine Cardiovascular Stroke Prevention Acute Ischaemic Stroke DVT/PE Reversal of Anti-coagulation Myocardial Infarction Hypertension Oncology Lung Cancer Respiratory Asthma COPD IPF SSc-ILD Central Nervous System Overview Metabolic Diseases Diabetes IntroDia Immunology Overview Animal Health Biopharma Careers Search form Search Select your area of interest / professional background General Information Patients & Carers Health Care Professional in the US Health Care Professional outside the US Journalists Jobseekers We passionately improve health Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies. - Annual Report 2016 Today, as a research-driven pharmaceutical company we focus more than ever on a variety of partnerships. Read more in our Annual Report 2016. Read moreon Annual Report 2016 Vision Our Vision The Boehringer Ingelheim group of companies' objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision. Watchthe video on Our Vision Research Approach Research & Development Research Approach Our new discovery research strategy aims at enhancing our capacity for innovation and at encouraging scientific creativity for diseases with high unmet medical need. Read moreon Research Approach Careers Working at Boehringer Ingelheim – Being part of a global family As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world. Read moreon Working at Boehringer Ingelheim – Being part of a global family - Animal Health: One business, one vision, one global leader in disease prevention and treatment By bringing together the best minds in the business, Boehringer Ingelheim and Merial have united to create one animal health company with the portfolio, scale and talent to make the industry even better at improving animal health. Read moreon Animal Health: One business, one vision, one global leader in disease prevention and treatment Play Pause Previous Next Explore Our Content PRESS RELEASE 29 Sep 2017 at 16:30 Boehringer Ingelheim and FEI partner to promote equine health and education Read moreon Boehringer Ingelheim and FEI partner to promote equine health and education Careers Discover our global career opportunities We offer a wide range of career development opportunities in over 140 affiliates worldwide. Click "Read more" to check out the local career sites. Read moreon Discover our global career opportunities EVENT September 29 2017 World Heart Day 2017 29 Sep 2017 08:00 AM Read moreon World Heart Day 2017 Making More Health Corporate Citizenship Making More Health (MMH) Our global MMH initiative identifies and supports innovative health solutions by focusing on social entrepreneurial activities and co-creation Read moreon Making More Health (MMH) Careers Career Blog Ask questions, get answers, receive tips, welcome to the Boehringer Ingelheim career blog Read moreon Career Blog Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim in the new “stop motion” video. History New history “stop motion” video Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim in the new “stop motion” video. Watchthe video on New history “stop motion” video Our Commitment to Diversity and Inclusion Diversity & Inclusion Our Commitment to Diversity and Inclusion For Boehringer Ingelheim, diversity and inclusion drives innovation. We foster an inclusive environment for innovation and growth. Read moreon Our Commitment to Diversity and Inclusion Professor Nowak Lung Cancer Mesothelioma: types, risk factors and prognosis for patients Prof. Nowak, Medical Oncologist at the University of Western Australia, discusses the different types of mesothelioma, risk factors and current prognosis for patients Watchthe video on Mesothelioma: types, risk factors and prognosis for patients Home: Homepage About Us Corporate Profile Press Careers Global Activities Innovation Research Boehringer Ingelheim Venture Fund Prescription Medicine Cardiovascular Oncology Respiratory Central Nervous System Metabolic Diseases Immunology Business Units Prescription Medicine Animal Health Biopharma Global Activities Africa Asia Australasia Europe North America South America Share Back To Top Facebook Twitter Youtube Linkedin Instagram Pinterest Rss Accessibility Statement Terms of Use Data Privacy Imprint © 2010-2017 Boehringer Ingelheim GmbH All rights reserved